drugset / Trial / NCT04661293
Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to autologous muscle derived cells (AMDCs). Treating physicians may submit requests for expanded access to Cook MyoSite's investigational product by email to [email protected].
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Autologous Muscle Derived Cells | Cell therapy | — | — |
Indications
No indication recorded.